Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...
Among older adults and adults with low atherosclerotic cardiovascular disease risk, use of aspirin decreased after 2019.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback